Jay Lichter, Director, 10% Owner at Janux Therapeutics, Inc. (JANX), bought 1,699,708 shares at $5.87 ($10.0M) on 2023-11-13, disclosed to the SEC on 2023-11-15.
Open-market purchase of $10.0M JANX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.87 | 849,854 | $5.0M | 50.0% |
| 2 | $5.87 | 849,854 | $5.0M | 50.0% |
| Total | $5.87 avg | 1,699,708 | $10.0M | 100% |
| Filing → |
| JANX | BUY | 2021-06-16 | $10.7M | — | Filing → |
| OTIC | SELL | 2021-03-03 | $1.7M | — | Filing → |
| OTIC | SELL | 2021-03-02 | $5.1M | — | Filing → |